Page 3 - PCC07

CONTENTS
Course coordination, course type, course description, target audience,
educational needs and expected outcomes 05
Programme 07 Speakers’ contributions
Notes
204
The pathophysiology of PCOS: What is it, what is the cause and what is the
prognosis for fertility and health? 11
Steve Franks (United Kingdom)
Androgen excess: Is it the driving force behind the syndrome and its health
implications? 38
Joop Laven (The Netherlands)
The diagnosis of PCOS: How is the work-up and what is new? 56
Helena Teede (Australia)
The PCO morphology criterion using ultrasound can be replaced by one AMH
measurement 75
Didier Dewailly (France)
Fertility treatment in PCOS: What to do step by step? Clomiphene, aromatase
inhibitors, metformin, weight reduction, FSH low dose step up 85
Richard Legro (U.S.A.)
Fertility treatment in PCOS: How does IVF fit in the treatment scheme,
and how to manage safety 121
Adam Balen (United Kingdom)
Fertility treatment in PCOS: How does ovarian drilling fit in the treatment
scheme, is this a safe procedure and why do we use it so infrequently? 143
Tin-Chiu Li (Hong Kong)
The pregnant PCOS patient and her offspring: implications of metabolic
derailment. What is the current management? 167
Daniela Romualdi (Italy)
Short and long term health consequences of the PCO Syndrome:
Comorbidity in PCOS: Psychological distress and endometrial health 184
Terhi Piltonen (Finland)
PRECONGRESS COURSE 07 I BARCELONA, SPAIN – 1 JULY 2018 03